Search results for " Blood transfusion"

showing 10 items of 13 documents

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspi…

2009

The prognosis for thalassemia major has dramatically improved in the last two decades. However, many transfusion-dependent patients continue to develop progressive accumulation of iron. This can lead to tissue damage and eventually death, particularly from cardiac disease. Previous studies that investigated iron chelation treatments, including retrospective and prospective non-randomised clinical trials, suggested that mortality, due mainly to cardiac damage, was reduced or completely absent in patients treated with deferiprone (DFP) alone or a combined deferiprone-deferoxamine (DFP-DFO) chelation treatment. However, no survival analysis has been reported for a long-term randomised control …

MaleThalassemiaKaplan-Meier Estimatelaw.inventionchemistry.chemical_compoundRandomized controlled triallawCause of DeathNeoplasmsDeferiproneProspective StudiesChildCause of deathHazard ratioHematologyMiddle AgedCombined Modality TherapySurvival RateThalassemia survival chelation treatment trial thalassemia majorCombinationSplenectomyMolecular MedicineDrug Therapy CombinationFemaleDeferiproneAdultmedicine.medical_specialtyAdolescentPyridonesDeferoxamineIron Chelating AgentsYoung AdultDrug TherapyInternal medicinemedicineHumansBlood TransfusionAdolescent; Adult; Blood Transfusion; Cause of Death; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Drug Therapy; Combination; Female; Heart Failure; Humans; Iron Chelating Agents; Kaplan-Meiers Estimate; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Prospective Studies; Pyridones; Splenectomy; Survival Rate; Young Adult; beta-ThalassemiaMolecular BiologySurvival rateKaplan-Meiers EstimateSurvival analysisProportional Hazards ModelsHeart Failurebusiness.industryProportional hazards modelbeta-ThalassemiaCell Biologymedicine.diseaseChelation TherapySurgerychemistrybusiness
researchProduct

Impact of perioperative transfusions and sepsis on long-term oncologic outcomes after curative colon cancer resection. A retrospective analysis of a …

2020

Objective: Intra-abdominal septic complications (IASC) affect short-term outcomes after surgery for colon cancer. Blood transfusions have been associated with worse short-term results.The role of IASC and blood transfusions on long-term oncologic results is still debated. This study aims to assess the impact of these two variables on survival after curative colon cancer resection. Patients and methods: Retrospective analysis of a prospectively maintained database of patients who underwent curative surgery for colon cancer at a university hospital, between 1993 and 2010. Cox regression was used to identify the role of IASC and transfusions (alone and combined) on local recurrence (LR), disea…

Malemedicine.medical_specialtyTime FactorsDatabases FactualSurvivalSepsiColorectal cancer030230 surgerycomputer.software_genre03 medical and health sciencesPostoperative Complications0302 clinical medicineSeptic complicationSepsisLocal recurrencemedicineHumansAnastomotic leakPerioperative PeriodAgedRetrospective StudiesAged 80 and overHepatologyDatabaseProportional hazards modelbusiness.industryMortality rateBlood transfusionHazard ratioGastroenterologyPerioperativeMiddle Agedmedicine.diseaseColorectal surgeryColon cancerSurvival RateBowel obstructionTreatment OutcomeAnastomotic leak Blood transfusion Colon cancer Complicaciones sépticas Complicación Complication Cáncer de colon Fuga anastomótica Local recurrence Recurrencia local Sepsis Septic complications Supervivencia Survival Transfusión de sangre030220 oncology & carcinogenesisColonic NeoplasmsFemaleComplicationbusinessComplicationcomputerSeptic complicationsGastroenterología y Hepatología
researchProduct

An overview of doping in sports

2019

The history of doping field can be outlined in three major stages: (1) early stage in which drug abuse took place during sports performance and competition and gas chromatography was used for its detection; (2) approximately in the 1970s when androgenic anabolic steroids were introduced; (3) In the recent era when the fields of biochemistry, physiology, toxicology, genomics, genetics, immunology, and molecular biology were integrated and applied routinely. Advanced omics technology and gene doping age may be applied in near future. This review will discuss commonly abused materials, both their adverse and harmful effects, and the alleged benefits in conjunction with the current standards in…

Bioquímicaprotein synthesis[SDV]Life Sciences [q-bio]anabolic androgenic steroidsPharmacologyProtein chemistry01 natural sciencesDopaje03 medical and health sciencesCondensed Matter::Materials SciencePhysics::Popular PhysicsBlood dopingerythropoiesis-stimulating agentsGene dopinghuman urineCondensed Matter::SuperconductivityToxicologíaComputer Science::Multimediaaromatase inhibition030304 developmental biology0303 health sciencesAromatase inhibitionbody compositionChemistryexogenous growth hormone010401 analytical chemistryMedicina deportivaskeletal muscle massAnabolic-Androgenic SteroidsSkeletal muscle massGenética3. Good health0104 chemical sciencesautologous blood transfusionsCondensed Matter::Strongly Correlated Electronshuman activitiesClinical psychology
researchProduct

Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (…

2017

MalePediatricsmedicine.medical_specialtyBlood transfusionReticulocytesAnemiamedicine.medical_treatmentSpherocytosisSpherocytosisMEDLINEErythrocyte Count; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Infant Newborn; Italy; Male; Recombinant Proteins; Reticulocytes; Retrospective Studies; Spherocytosis Hereditary; Blood Transfusion; HematologyHereditary spherocytosis03 medical and health sciencesHemoglobins0302 clinical medicinemedicineHumansBlood TransfusionRecombinant erythropoietinErythropoietinErythrocyte Count; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Humans; Infant; Infant Newborn; Italy; Male; Recombinant Proteins; Reticulocytes; Retrospective Studies; Spherocytosis Hereditary; Blood TransfusionRetrospective Studiesbusiness.industryInfantRetrospective cohort studyHematologymedicine.diseaseNewbornRecombinant ProteinsSurgeryHereditaryItalyErythropoietin030220 oncology & carcinogenesisErythrocyte Count030211 gastroenterology & hepatologyFemalebusinessmedicine.drugFollow-Up Studies
researchProduct

Accuracy of blood transfusion in postpartum hemorrhage to assess maternal morbidity.

2012

International audience; OBJECTIVE: To measure the accuracy of blood transfusion (timing and number of blood units) in postpartum hemorrhage (PPH) in a perinatal network. STUDY DESIGN: (1) The ANONYMAT software system was used for anonymization and linkage of two large stand-alone databases, the Burgundy Perinatal Network (BPN) and the National Blood Centre (EFS) databases, which contain, respectively, clinical data from hospital discharges and information concerning any blood transfusion in France (considered as the gold standard database for identifying any transfusion). (2) Identification of prescriptions of at least one red blood cell (RBC) unit at the day of delivery (≥22 weeks) and up …

PediatricsBlood transfusionmedicine.medical_treatment0302 clinical medicineMESH: PregnancyBlood productPregnancyPerinatal networkMESH : Blood Transfusion[ SDV.IMM ] Life Sciences [q-bio]/ImmunologyMESH : Female030212 general & internal medicineMESH : Obstetrics030219 obstetrics & reproductive medicineObstetricsMedical recordObstetrics and GynecologyMESH: Postpartum HemorrhageMESH: Predictive Value of Tests3. Good healthObstetricsBlood units[SDV.IMM]Life Sciences [q-bio]/ImmunologyFemaleFranceMESH : Sensitivity and SpecificityMESH: Obstetricsmedicine.medical_specialty[SDV.IMM] Life Sciences [q-bio]/ImmunologyMaternal morbidityMESH: Blood TransfusionMESH : Postpartum HemorrhageSensitivity and Specificity03 medical and health sciencesPredictive Value of TestsmedicineHumansBlood TransfusionMESH : Predictive Value of TestsMedical prescriptionMESH : FranceMESH: Humansbusiness.industryPostpartum HemorrhageMESH : HumansGold standard (test)MESH: Sensitivity and SpecificityMESH: FranceMESH : PregnancyReproductive MedicinebusinessMESH: Female
researchProduct

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with adv…

2012

Purpose The combination of pertuzumab and trastuzumab resulted in a clinical benefit rate (CBR) of 50% in patients with human epidermal growth factor receptor 2 (HER2) –positive breast cancer whose disease progressed during prior trastuzumab-based therapy. To define whether this previously observed encouraging activity was a result of the combination of pertuzumab and trastuzumab or of pertuzumab alone, we recruited a third cohort of patients who received pertuzumab without trastuzumab. We then investigated the impact of reintroducing trastuzumab to patients whose disease progressed on pertuzumab monotherapy. Patients and Methods Twenty-nine patients with HER2-positive breast cancer whose d…

OncologyCancer ResearchReceptor ErbB-2MESH: Risk AssessmentMESH: Dose-Response Relationship Drug0302 clinical medicineTrastuzumabAntineoplastic Combined Chemotherapy ProtocolsMedicineProspective StudiesProspective cohort studyskin and connective tissue diseasespertuzumab; trastuzumab; breast cancerMESH: Treatment OutcomeMESH: Aged0303 health sciencesMESH: Middle AgedMESH: ErythrocytesAge FactorsMESH: Maximum Tolerated DoseMESH: Neoplasm StagingMiddle AgedPrognosis3. Good healthtrastuzumabMESH: Antineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeOncologyTolerabilityMESH: Receptor erbB-2030220 oncology & carcinogenesisMESH: Survival AnalysisDisease Progression[SDV.IMM]Life Sciences [q-bio]/ImmunologyMESH: Disease ProgressionFemalePertuzumabmedicine.drugAdultmedicine.medical_specialty[SDV.IMM] Life Sciences [q-bio]/ImmunologyMaximum Tolerated DoseMESH: Blood TransfusionBreast NeoplasmsMESH: Drug Administration ScheduleAntibodies Monoclonal HumanizedLoading doseMESH: Cell SeparationRisk AssessmentMESH: PrognosisDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesbreast cancerBreast cancerMESH: PrionspertuzumabInternal medicineHumansMESH: Patient SelectionNeoplasm InvasivenessneoplasmsSurvival analysis030304 developmental biologyAgedNeoplasm StagingMESH: Age FactorsMESH: HumansDose-Response Relationship Drugbusiness.industryPatient SelectionMESH: AdultMESH: Neoplasm InvasivenessMESH: Creutzfeldt-Jakob SyndromeTrastuzumabmedicine.diseaseSurvival AnalysisMESH: Prospective StudiesMESH: Antibodies Monoclonal HumanizedMESH: Disease-Free SurvivalbusinessMESH: FemaleProgressive diseaseMESH: Breast NeoplasmsJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Transfusion‐transmitted malaria of plasmodium malariae in palermo, sicily

2021

Transfusion-transmitted malaria (TTM) is a rare occurrence with serious consequences for the recipient. In non-endemic areas, the incidence of transmission of malaria by transfusion is very low. We report a clinical case of transfusion-transmitted malaria due to Plasmodium malariae, which happened in a patient with acute hemorrhagic gastropathy. Case presentation: In April 2019, a 70-year-old Italian man with recurrent spiking fever for four days was diagnosed with a P. malariae infection, as confirmed using microscopy and real-time PCR. The patient had never been abroad, but about two months before, he had received a red blood cell transfusion for anemia. Regarding the donor, we revealed t…

Pediatricsmedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaBlood transfusionLeadership and ManagementAnemiamedicine.medical_treatmentmalariaCase ReportthrombocytopeniaHealth InformaticsPlasmodium malariaeParasitemiablood transfusionblood donor screeningAsymptomaticPlasmodium malariaetransfusion-transmitted malariaHealth Information ManagementAsymptomatic semi‐immune donors Blood donor screening Blood transfusion Malaria Plasmodium malariae Thrombocytopenia Transfusion-transmitted malaria<i>Plasmodium malariae</i>parasitic diseasesmedicinebiologybusiness.industryHealth PolicyIncidence (epidemiology)Rbiology.organism_classificationmedicine.diseaseDiagnosis of malariaasymptomatic semi-immune donorsMedicinemedicine.symptombusinessMalaria
researchProduct

Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant …

2020

GETH (Grupo Español de Trasplante Hematopoyético y Terapia Celular).

medicine.medical_specialtymedicine.drug_classmedicine.medical_treatment1700Antibioticslcsh:MedicinemicrobiomeGraft vs Host DiseaseHematopoietic stem cell transplantationantibioticsAntimicrobial StewardshipFecesInternal medicinegraft versus host diseasemicrobiotamedicineHumansMulticenter Studies as Topic1506infectionsLongitudinal StudiesProspective StudiesAntibiotic prophylaxisbusiness.industryIncidence (epidemiology)lcsh:RHematopoietic Stem Cell TransplantationGeneral MedicineAntibiotic Prophylaxismedicine.diseaseTransplant RecipientsGastrointestinal MicrobiomeTransplantationObservational Studies as Topicsurgical procedures operativeGraft-versus-host diseaseResearch DesignCase-Control StudiesCohortObservational studybusinessHaematology (Incl Blood Transfusion)BMJ Open
researchProduct

NS5A gene analysis by next generation sequencing in HCV nosocomial transmission clusters of HCV genotype 1b infected patients

2019

Background: The aim of the study was to investigate the intra-host variability through next-generation-sequencing (NGS) of the NS5A-gene in nosocomial transmission-clusters observed in two Italian hospitals among hepatitis C virus (HCV)-genotype-1b infected patients. Methods: HCV-sequencing was performed by Sanger-sequencing (NS3 + NS5A + NS5B) and by NGS (NS5A, MiSeq-Illumina) in 15 HCV-1b infected patients [five acute with onco-hematologic-disease and 10 (4/6 acute/chronic) with &beta

Male0301 basic medicinevirusesDrug ResistanceHepacivirusViral Nonstructural Proteinsmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataGastroenterologySettore MED/07chemistry.chemical_compound0302 clinical medicineGenotype 1bMedicineVirallcsh:QH301-705.5PhylogenyCross Infectionnosocomial transmissionGastroenterologyHigh-Throughput Nucleotide Sequencingvirus diseasesHCV; NGS; acute infection; chronic infection; nosocomial transmission; sequencing; Acute Disease; Adult; Amino Acid Substitution; Antiviral Agents; Blood Transfusion; Chronic Disease; Cross Infection; Drug Resistance Viral; Female; Genotype; Hepacivirus; Hepatitis C; High-Throughput Nucleotide Sequencing; Host-Pathogen Interactions; Humans; Interferons; Male; Middle Aged; Phylogeny; Polymorphism Single Nucleotide; Viral Nonstructural Proteins; beta-ThalassemiaSingle NucleotideGeneral MedicinesequencingMiddle AgedHepatitis CNGSAcute DiseaseHost-Pathogen InteractionsHCVFemale030211 gastroenterology & hepatologyAdultmedicine.medical_specialtyGenotypeHepatitis C virusViral quasispeciesPolymorphism Single NucleotideAntiviral AgentsArticleDNA sequencing03 medical and health sciencesInternal medicineDrug Resistance ViralHumansBlood TransfusionPolymorphismNS5ANS5BGeneHepatologybusiness.industryNosocomial transmissionbeta-Thalassemiabiochemical phenomena metabolism and nutritionchronic infectionVirologydigestive system diseasesChronic infection030104 developmental biologyAmino Acid Substitutionchemistrylcsh:Biology (General)Chronic DiseaseHCV; NGS; acute infection; chronic infection; nosocomial transmission; sequencingInterferonsbusinessacute infectionDigestive and Liver Disease
researchProduct

Intraoperative transfusion practices in Europe

2016

PubMed: 26787795

AUSTRIAN BENCHMARKMaleBlood transfusionmedicine.medical_treatment610 Medizinanaemia anesthesia blood transfusion surgery transfusion trigger030204 cardiovascular system & hematologyGUIDELINESsurgeryCohort Studies0302 clinical medicine030202 anesthesiologyMedicine and Health SciencesMedicineProspective StudiesProspective cohort studyddc:610Research Support Non-U.S. Gov'tMiddle AgedHospitalsEuropeFemaleAllogeneic transfusionCohort studymedicine.medical_specialtyTransfusion rateObservational Studyanesthesiablood transfusionELECTIVE SURGERYClinical Practice03 medical and health sciencesJournal Articleanaemia ; anesthesia ; blood transfusion ; surgery ; transfusion triggerHumansBlood TransfusionElective surgeryCHLC ANSIntensive care medicineanaemiatransfusion triggerIntraoperative Carebusiness.industryPREOPERATIVE ANEMIAPATIENT BLOOD MANAGEMENTClinical trialAnesthesiology and Pain MedicineEmergency medicinebusinessPacked red blood cellsREQUIREMENTSBritish journal of anaesthesia
researchProduct